Abstract
Chronic constipation is a highly prevalent and often under-appreciated gastrointestinal disorder in PD associated with significant impairment in quality of life. In this study, we investigated the efficacy and safety of PHGG plus hyaluronate (PHGG+) in patients suffering from PD and constipation. Thirty-four PD patients have been recruited in an open-label pilot study and measured symptoms and quality of life instruments related to constipation. PHGG+ showed to have a minimal still significant effect in improving constipation as measured by PAC Symp and CGI-S. PHGG+ is safe and well tolerated. Data suggests that PHGG+ may be considered efficacious in alleviating symptoms of constipation in PD patients. Trial registration number: NCT04569656/24 Sept. 2020
Similar content being viewed by others
References
Kaye J, Gage H, Kimber A, Storey L, Trend P (2006) Excess burden of constipation in Parkinson’s disease: a pilot study. Mov Disord 21:1270–1273
Brandt LJ, Schoenfeld P, Prather CM, Schiller LR, Schoenfeld P, Talley NJ (2005) An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 100:S5–S22
Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 14:625–639
Knudsen K, Krogh K, Ostergaard K, Borghammer P (2017) Constipation in Parkinson’s Disease: subjective symptoms, objective markers, and new prospective. Mov Disord 32(1):94–105
Stocchi F, Badiali D, Vacca L, D’Alba L, Bracci F, Ruggieri S, Torti M, Berardelli A, Corazziari E (2000) Anorectal function in multiple systematrophy and Parkinson’s disease. Mov Disord 15(1):71–76
Duncan GW, Khoo TK, Yarnall AJ, O’Brien JT, Coleman SY, Brooks DJ et al (2014) Health-related quality of life in early Parkinson’s disease: the impact of non-motor symptoms. Mov Disord 2:195–202
High fibre and guar gum are equally helpful in IBS, but gum is better tolerated (2002) BMJ. Dec 7; 325(7376)
Russo L, Andreozzi P, Zito FP, Vozzella L, Savino IG, Sarnelli G, Cuomo R (2015) Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index. Saudi J Gastroenterol 21(2):104–110
Pedrosa AJ, Carrasco (2018) Management of constipation in patients with Parkinson’s disease. NPJ Parkinson’s Disease 4:6
Braak H, Rüb U, Gai WP, del Tredici K (2003) Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517–536
Hawkes CH, del Tredici K, Braak H (2007) Parkinson’s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33:599–614
Hawkes CH, del Tredici K, Braak H (2009) Parkinson’s disease: the dual hit theory revisited. Ann N Y Acad Sci 1170:615–622
Nair AT, Ramachandran V, Joghee NM, Antony S, Ramalingam G (2018) Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson’s disease: a critical review. J Neurogastroenterol Motil 24:30–42
Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P (2015) Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 30:350–358
Orimo S, Ghebremedhin E, Gelpi E (2018) Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD. Cell Tissue Res 373(1):267–286
Availability of data and material
The data set is available if required.
Author information
Authors and Affiliations
Contributions
All the authors contributed to the ideation and conduction of the study. The manuscript has been revised by all the authors who contributed to it.
Corresponding author
Ethics declarations
Ethical approval
The study was approved by IRCCS San Raffaele IRB.
Conflict of interest
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vacca, L., Proietti, S., Bravi, D. et al. Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson’s disease: a pilot study. Neurol Sci 43, 1055–1059 (2022). https://doi.org/10.1007/s10072-021-05342-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05342-8